Anna Berkenblit
advocate
Anna Berkenblit is the head of the Pancreatic Cancer Action Network, who praised the rapid approval of daraxonrasib, highlighting its potential to significantly change treatment outcomes for patients with pancreatic cancer.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Greece:
Anna Berkenblit praised the rapid approval, stating that the drug could radically change the landscape.
8
Debbie Orcutt
Andrew Nixon
Brian Wolpin
Lei Zheng
Kevan Shokat
Mark Goldsmith
Pranati Perati
Marty Makary
Kathimerini: Πειραματικό χάπι γεννά ελπίδες για έναν από τους πιο θανατηφόρους καρκίνους